Southern Star Research Logo

Meet us at BIO International Convention

June 16-19, 2025
Boston, USA
Home Events

Southern Star Research at BIO International Convention 2025

Southern Star Research is excited to attend the BIO International Convention 2025 in Boston—the world’s largest gathering of biotechnology leaders, representing the full global ecosystem of innovation, investment, and opportunity.

With a strong local and global presence, Southern Star Research delivers tailored support to early-phase biotech companies looking to grow, scale, and attract investment. Whether you’re an investor, financial advisor, or an emerging biotech leader, our team is ready to connect and collaborate.

Why Meet with Southern Star Research at BIO 2025?

  • Strategic insights tailored for early-phase biotech in the US
  • Proven frameworks that help startups scale, meet milestones, and attract funding
  • A global perspective with a deep understanding of US market dynamics
  • The Australian Advantage – leverage Australia’s fast, cost-effective, and globally recognized clinical research environment

📍 Let’s connect in Boston
Join us from June 16–19 at BIO 2025 and discover how Southern Star Research can support your clinical trials plans. Fill out the form below to schedule a meeting with our team.

Schedule a meeting

The Australian Advantage

Cost

Eligible organisations receive a 43.5% cash rebate on trial costs with the Australian Research & Development tax incentive.

Speed

Get you trial up and running in 8 weeks with streamlined ethics approvals and no need for an Investigational New Drug application.

Quality

World-class healthcare facilities and renowned experts ensure your data is accepted by international regulatory bodies like the FDA and EMA.

Come and meet us

Our team will be available throughout this event to discuss how we can support your research initiatives. Whether you’re looking to start a new project, save an existing one or simply explore new partnership opportunities, we’re here to help.

Dr David Lloyd

Managing Director

  • 30 years of research experience in academia, pharma & CROs
  • Advisor to the Australian Government on Clinical Research reforms
  • Prominent industry positions including Co-Chair of the R&D Taskforce
  • Appointed to NSW Dept of Health Early Phase Expert Oversight Committee
  • Previous member of several NHMRC committees overseeing clinical research

 

Dan Evans

Daniel Evans

Director, Business Development

  • Located in Sydney, Australia
  • 10+ years of experience in biotech consulting and CRO industry
  • Strong expertise in global business development for biotech and pharma
  • Deep understanding of biotech needs and challenges
  • Extensive experience in partnering with global biotech to deliver fast, cost-effective, high-quality clinical trial.
Rob Kent

Robert Kent

Senior Director, Business Development

  • Located in West Coast, USA
  • Nurse and healthcare professional
  • Decades of CRO business development experience
  • Deep experience in partnering with medical device, pharmaceutical, and biotechnology companies in USA & Europe
Head Office:
Phone: +61 2 9011 6266

L1, 1 Merriwa Street,

Gordon, NSW, 2072 Australia

E: info@southernstarresearch.com 

Connect with us
About Us Careers Services News Contact Us
Early Phase Specialist CRO Clinical Operations Biometrics Safety and Medical Monitoring Medical Writing

Sign up to our newsletter

Keep up to date with the latest news, updates and promotions

Copyright 2025 Southern Star Research Pty Ltd

Privacy Policy Legal Notice
icon of a head

Specialist experience

Each member of our Leadership Team boasts an average of 30 years experience. Our clients have access to an extraordinary group of Clinical Research professionals, whose experience covers Multinational Pharmaceutical companies, Biotechnology, Medical Device, CRO’s, research institutes, Universities, Industry Associations & Government Bodies. Together, we ensure that every aspect of your unique and novel drug study  clinical trial is handled with scientific precision, care, and foresight.

Our team has all of the tools, knowledge and experience to solve almost any issue that may arise during the complex clinical trial process.

We recognize that each study is unique and different and there are nuances that need to be resolved proactively.

Our advisory board of top-tier specialists in multiple therapeutic areas engage in the early stages from protocol design in constructive discussions to anticipate challenges and enhance study efficiency throughout the study.